Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catatonia | 3 | 2023 | 13 | 1.530 |
Why?
|
| Autism Spectrum Disorder | 4 | 2022 | 418 | 1.510 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 2 | 2021 | 18 | 1.280 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2023 | 30 | 0.830 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 11 | 0.810 |
Why?
|
| Encephalitis | 2 | 2023 | 137 | 0.740 |
Why?
|
| Adolescent Development | 1 | 2020 | 89 | 0.630 |
Why?
|
| Electroconvulsive Therapy | 1 | 2018 | 16 | 0.580 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.510 |
Why?
|
| Medical Records | 1 | 2017 | 185 | 0.480 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 545 | 0.470 |
Why?
|
| Puberty | 3 | 2022 | 152 | 0.470 |
Why?
|
| Body Mass Index | 2 | 2022 | 2390 | 0.460 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 604 | 0.400 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 390 | 0.390 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 139 | 0.350 |
Why?
|
| Internship and Residency | 1 | 2017 | 1230 | 0.240 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 2929 | 0.230 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 463 | 0.220 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 141 | 0.220 |
Why?
|
| Child | 11 | 2023 | 22390 | 0.220 |
Why?
|
| Adolescent | 9 | 2023 | 22116 | 0.200 |
Why?
|
| Aggression | 1 | 2023 | 194 | 0.180 |
Why?
|
| Confusion | 1 | 2021 | 31 | 0.180 |
Why?
|
| Hospitalization | 2 | 2022 | 2264 | 0.170 |
Why?
|
| Female | 12 | 2023 | 75814 | 0.160 |
Why?
|
| Delirium | 1 | 2021 | 105 | 0.160 |
Why?
|
| Humans | 16 | 2023 | 141284 | 0.150 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 40 | 0.150 |
Why?
|
| Endocrine System Diseases | 1 | 2019 | 35 | 0.150 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 55 | 0.140 |
Why?
|
| Malnutrition | 1 | 2019 | 84 | 0.140 |
Why?
|
| Physical Examination | 1 | 2019 | 243 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2022 | 493 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 282 | 0.130 |
Why?
|
| Male | 10 | 2023 | 70140 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2023 | 802 | 0.130 |
Why?
|
| Communicable Diseases | 1 | 2019 | 162 | 0.130 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 178 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2018 | 162 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2020 | 783 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 278 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 5653 | 0.120 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 189 | 0.120 |
Why?
|
| Self Report | 1 | 2019 | 859 | 0.110 |
Why?
|
| Seizures | 1 | 2018 | 441 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 552 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2020 | 698 | 0.110 |
Why?
|
| Mental Health | 1 | 2020 | 756 | 0.100 |
Why?
|
| Mass Screening | 1 | 2021 | 1309 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2020 | 1133 | 0.090 |
Why?
|
| Parents | 1 | 2019 | 1439 | 0.080 |
Why?
|
| Poverty | 1 | 2013 | 527 | 0.070 |
Why?
|
| Motor Activity | 1 | 2013 | 717 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 2210 | 0.070 |
Why?
|
| Students | 1 | 2013 | 644 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2069 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2017 | 3522 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2022 | 1449 | 0.060 |
Why?
|
| Risk Factors | 1 | 2017 | 10490 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 414 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 370 | 0.040 |
Why?
|
| Streptolysins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 75 | 0.040 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 12 | 0.040 |
Why?
|
| United States | 1 | 2017 | 15298 | 0.040 |
Why?
|
| Lorazepam | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 26 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 67 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2019 | 56 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2017 | 16447 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 145 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 7805 | 0.030 |
Why?
|
| Comorbidity | 1 | 2023 | 1671 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 655 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 215 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 1078 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 868 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1491 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2795 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1764 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 915 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 39319 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 3345 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 913 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 267 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 1466 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5809 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5222 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 6270 | 0.020 |
Why?
|
| Schools | 1 | 2013 | 451 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 11511 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 9820 | 0.020 |
Why?
|